ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors

[摘要]

[发布日期] 2015-01-15 [发布机构]

[效力级别] [学科分类]

[关键词] Vemurafenib;ErbB3 Receptor;Melanoma Cell Growth;Anti ErbB3 Antibody;V600R Mutation [时效性]

浏览次数：3